Edwards Lifesciences Corp [NYSE: EW] stock went on an upward path that rose over 0.80% on Wednesday, amounting to a one-week price increase of more than 1.01%.
Over the last 12 months, EW stock rose by 3.89%. The one-year Edwards Lifesciences Corp stock forecast points to a potential upside of 7.79. The average equity rating for EW stock is currently 2.12, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $45.12 billion, with 586.20 million shares outstanding and 574.69 million shares in the current float. Compared to the average trading volume of 4.27M shares, EW stock reached a trading volume of 5237196 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Edwards Lifesciences Corp [EW]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EW shares is $83.41 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EW stock is a recommendation set at 2.12. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Edwards Lifesciences Corp shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 24, 2025. While these analysts kept the previous recommendation, Stifel raised their target price from $75 to $90. The new note on the price target was released on January 30, 2025, representing the official price target for Edwards Lifesciences Corp stock. Previously, the target price had yet another raise to $60, while Wolfe Research analysts kept a Underperform rating on EW stock.
The Price to Book ratio for the last quarter was 4.45, with the Price to Cash per share for the same quarter was set at 6.65. Price to Free Cash Flow for EW in the course of the last twelve months was 71.26 with Quick ratio for the last quarter at 3.66.
EW Stock Performance Analysis:
Edwards Lifesciences Corp [EW] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.01. With this latest performance, EW shares gained by 2.11% in over the last four-week period, additionally plugging by 9.92% over the last 6 months – not to mention a rise of 3.89% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EW stock in for the last two-week period is set at 51.79, with the RSI for the last a single of trading hit 1.34, and the three-weeks RSI is set at 1.45 for Edwards Lifesciences Corp [EW]. The present Moving Average for the last 50 days of trading for this stock 76.59, while it was recorded at 76.49 for the last single week of trading, and 72.50 for the last 200 days.
Insight into Edwards Lifesciences Corp Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Edwards Lifesciences Corp [EW] shares currently have an operating margin of 26.92% and a Gross Margin at 78.59%. Edwards Lifesciences Corp’s Net Margin is presently recorded at 16.03%.
Edwards Lifesciences Corp (EW) Capital Structure & Debt Analysis
According to recent financial data for Edwards Lifesciences Corp. ( EW), the Return on Equity (ROE) stands at 16.73%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 12.68%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Edwards Lifesciences Corp’s Return on Invested Capital (ROIC) is 8.22%, showcasing its effectiveness in deploying capital for earnings.
Edwards Lifesciences Corp (EW) Efficiency & Liquidity Metrics
Based on Edwards Lifesciences Corp’s (EW) latest financial statements, the Debt-to-Equity Ratio is 0.07%, indicating its reliance on debt financing relative to shareholder equity.
Edwards Lifesciences Corp (EW) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Edwards Lifesciences Corp. (EW) effectively leverages its workforce, generating an average of $56196.2 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.45% and a Quick Ratio of 3.66%, indicating strong ability to cover short-term liabilities.
EW Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EW. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Edwards Lifesciences Corp go to 8.58%.
Edwards Lifesciences Corp [EW] Institutonal Ownership Details
There are presently around $88.99%, or 89.80% of EW stock, in the hands of institutional investors. The top three institutional holders of EW stocks are: VANGUARD GROUP INC with ownership of 53.58 million shares, which is approximately 8.8982%. BLACKROCK INC., holding 50.98 million shares of the stock with an approximate value of $$4.71 billion in EW stocks shares; and BLACKROCK INC., currently with $$2.4 billion in EW stock with ownership which is approximately 4.3197%.
